Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Common Equity (2016 - 2026)

Healthequity has reported Common Equity over the past 13 years, most recently at $2.1 billion for Q1 2026.

  • Quarterly results put Common Equity at $2.1 billion for Q1 2026, changed 0.36% from a year ago — trailing twelve months through Jan 2026 was $2.1 billion (changed 0.36% YoY), and the annual figure for FY2026 was $2.1 billion, changed 0.36%.
  • Common Equity for Q1 2026 was $2.1 billion at Healthequity, down from $2.1 billion in the prior quarter.
  • Over the last five years, Common Equity for HQY hit a ceiling of $2.2 billion in Q3 2024 and a floor of $1.9 billion in Q1 2022.
  • Median Common Equity over the past 5 years was $2.0 billion (2024), compared with a mean of $2.0 billion.
  • Biggest five-year swings in Common Equity: soared 34.37% in 2022 and later decreased 0.49% in 2025.
  • Healthequity's Common Equity stood at $1.9 billion in 2022, then grew by 5.57% to $2.0 billion in 2023, then grew by 6.88% to $2.1 billion in 2024, then increased by 0.44% to $2.1 billion in 2025, then fell by 1.26% to $2.1 billion in 2026.
  • The last three reported values for Common Equity were $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025) per Business Quant data.